NCT02225145View on ClinicalTrials.gov

Fertility Preservation in Women Who Will Have Gonadotoxic Therapy or Hematopoetic Stem Cell Transplantation, and in Women With Sickle Cell Disease

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 15, 2014

Primary Completion Date

September 9, 2016

Study Completion Date

September 20, 2017

Conditions

HemoglobinStem Cell TransplantAplastic Anemia

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT02225145 - Fertility Preservation in Women Who Will Have Gonadotoxic Therapy or Hematopoetic Stem Cell Transplantation, and in Women With Sickle Cell Disease | Biotech Hunter | Biotech Hunter